6CM
DTIL icon

683 Capital Management’s Precision BioSciences DTIL Stock Holding History

683 Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-97,085
Closed -$404K – 246
2025
Q4 		$404K Buy
+97,085
New +$551K 0.02% 206

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

683 Capital Management's DTIL Position: Q1 2026 in Review

683 Capital Management sold out of Precision BioSciences (DTIL) in Q1 2026, closing a stake of 97,085 shares — an estimated $404K sold.

683 Capital Management first reported a position in DTIL in Q4 2025 and held it in 1 quarter. The position peaked at $404K in Q4 2025. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • 683 Capital Management reported no remaining Precision BioSciences position as of Q1 2026 after selling out during the quarter.
  • 683 Capital Management sold 97,085 Precision BioSciences shares in Q1 2026, an estimated $404K.
  • 683 Capital Management first reported a position in Precision BioSciences in Q4 2025 and held it in 1 quarter.
  • 683 Capital Management's Precision BioSciences position peaked at $404K in Q4 2025.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.